福元医药(601089.SH)：联苯苄唑溶液获得药品注册证书

Core Viewpoint - Fuyuan Pharmaceutical (601089.SH) has received a drug registration certificate from the National Medical Products Administration for its product, a 1% solution of bifonazole, which is approved for production [1]. Group 1: Product Approval - Fuyuan Pharmaceutical's wholly-owned subsidiary, Fuyuan Pharmaceutical Co., Ltd., has been granted a drug registration certificate for bifonazole solution (specification: 1% (10ml: 0.1g)) [1]. - The drug is indicated for the treatment of various skin fungal diseases, including tinea (foot, body, and groin), candidiasis (interdigital maceration, intertrigo, and cutaneous candidiasis), and vitiligo [1].